DSpace at RU >

Browsing by Author Wit, J.M.

Full Text	Issue Date	Title	Author(s)
	2011	Case report: low circulating IGF-I levels due to Acid-Labile Subunit deficiency in adulthood are not associated with early development of atherosclerosis and impaired heart function	Rensing, K.L.; Duyvenvoorde, H.A. van; Cramer, M.J., et al
	1996	Catch-up growth after prolonged hypothyroidism	Boersma, B.; Otten, B.J.; Stoelinga, G.B.A., et al
	2008	Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis.	Bon, B.W.M. van; Koolen, D.A.; Borgatti, R., et al
	2005	Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.	Kamp, H.J. van de; Oudshoorn, C.G.; Elvers, B.H., et al
	1997	Effect of growth hormone treatment on craniofacial growth in Turner's syndrome	Rongen, C.; Born, E. van de; Prahl-Andersen, B., et al
	2010	The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome.	Menke, L.A.; Sas, T.C.J.; Zandwijken, G.R., et al
	2011	Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome	Menke, L.A.; Sas, T.C.J.; Stijnen, T., et al
	2011	The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome	Menke, L.A.; Sas, T.C.J.; Koningsbrugge, S.H. van, et al
	2010	The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.	Menke, L.A.; Sas, T.C.J.; Visser, M. de, et al
	2009	Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.	Lind van Wijngaarden, R.F. de; Siemensma, E.P.; Festen, D.A., et al
	2010	Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.	Menke, L.A.; Sas, T.C.J.; Muinck Keizer-Schrama, S.M.P.F. de, et al
	2011	Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences.	Vries, M.C. de; Houtlosser, M.; Wit, J.M., et al
	2002	Final height gain by GH therapy in children with idiopathic short stature is dose dependent.	Wit, J.M.; Rekers-Mombarg, L.T.M.
	2007	Functional outcomes and participation in young adulthood for very preterm and very low birth weight infants: the Dutch Project on Preterm and Small for Gestational Age Infants at 19 years of age.	Hille, E.T.; Weisglas-Kuperus, N.; Goudoever, J.B. van, et al
	2011	Genome-wide screening in human growth plates during puberty in one patient suggests a role for RUNX2 in epiphyseal maturation.	Emons, J.; Dutilh, B.E.; Decker, E., et al
	2004	Genotype-phenotype correlation in patients suspected of having sotos syndrome.	Boer, L.M.; Kant, S.; Karperien, M., et al
	1997	Growth before and during growth hormone treatment in children operated for craniopharyngioma	Hogeveen, M.; Noordam, C.; Otten, B.J., et al
	1995	Growth hormone treatment in two dose regiments in girls with Turner syndrome: final height results	Massa, G.G.; Otten, B.J.; Muinck Keizer-Schrama, S.M.P.F. de, et al
	2008	Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit.	Duyvenvoorde, H.A. van; Kempers, M.J.E.; Twickler, T.B., et al
	2009	Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.	Domene, H.M.; Hwa, V.; Argente, J., et al